Philip A. DeSimone, MD

Clinical interests

  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Hematology
  • Medical Oncology

Philip A. DeSimone, MD

Biography

My name is Philip DeSimone; I received my medical degree from the University of Vermont, College of Medicine, Burlington. I completed a fellowship in Medical Oncology and Hematology at the University of Kentucky, Lexington.

I am board certified by the American Board of Internal Medicine in Hematology.

Faculty rank

Professor of Medicine

Education

Degree
University of Vermont, College of Medicine, Burlington

Residency
University of Kentucky, Lexington

Fellowship
Medical Oncology and Hematology, University of Kentucky, Lexington

Certifications or Special training
American Board of Internal Medicine
American Board of Internal Medicine, Hematology

Gastrointestinal Cancer

Multidisciplinary Clinic

Markey Cancer Center
Whitney-Hendrickson Building
First Floor
800 Rose St.
Lexington KY 40536-0098

HBCicon120x123
This is a clinic of the University of Kentucky Hospital, also known as UK Albert B. Chandler Hospital. Read more »

Call 859-257-4488
Call 866-340-4488

Directions to Markey Cancer Center »



Liver Cancer

Markey Cancer Center
Whitney-Hendrickson Building
First Floor
800 Rose St.
Lexington KY 40536-0098



Medical Oncology

Multidisciplinary Clinic

Markey Cancer Center
Whitney-Hendrickson Building
Room 134
800 Rose St.
Lexington KY 40536-0098

Call 859-323-5275
Call 859-323-8043
Fax 859-257-3757

Directions to Markey Cancer Center »


UK HealthCare accepts many forms of insurance. See list of insurers »

 

Recent Publications

(Five most recent publications from PubMed via an automated list based on the provider’s ID and the University of Kentucky.)
  1. Arnold SM, Rinehart JJ, Tsakalozou E, Eckardt JR, Fields SZ, Shelton BJ, DeSimone PA, Kee BK, Moscow JA, Leggas M.
    A phase I study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin in adult patients with refractory or metastatic solid malignancies.
    Clin Cancer Res. 2010 Jan 15;16(2):673-80.
  2. Bence AK, Anderson EB, Halepota MA, Doukas MA, DeSimone PA, Davis GA, Smith DA, Koch KM, Stead AG, Mangum S, Bowen CJ, Spector NL, Hsieh S, Adams VR.
    Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects.
    Invest New Drugs. 2005 Jan;23(1):39-49.
  3. Thompson JS, Haist SA, DeSimone PA, Engelberg J, Rich EC.
    The accelerated internal medicine program at the University of Kentucky.
    Ann Intern Med. 1992 Jun 15;116(12 Pt 2):1084-7.

View this provider on PubMed